Correlation Between Tastemaker Acquisition and Lyra Therapeutics
Can any of the company-specific risk be diversified away by investing in both Tastemaker Acquisition and Lyra Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tastemaker Acquisition and Lyra Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tastemaker Acquisition Corp and Lyra Therapeutics, you can compare the effects of market volatilities on Tastemaker Acquisition and Lyra Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tastemaker Acquisition with a short position of Lyra Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tastemaker Acquisition and Lyra Therapeutics.
Diversification Opportunities for Tastemaker Acquisition and Lyra Therapeutics
-0.84 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Tastemaker and Lyra is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Tastemaker Acquisition Corp and Lyra Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyra Therapeutics and Tastemaker Acquisition is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tastemaker Acquisition Corp are associated (or correlated) with Lyra Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyra Therapeutics has no effect on the direction of Tastemaker Acquisition i.e., Tastemaker Acquisition and Lyra Therapeutics go up and down completely randomly.
Pair Corralation between Tastemaker Acquisition and Lyra Therapeutics
If you would invest 1,076 in Tastemaker Acquisition Corp on September 1, 2024 and sell it today you would earn a total of 0.00 from holding Tastemaker Acquisition Corp or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 0.37% |
| Values | Daily Returns |
Tastemaker Acquisition Corp vs. Lyra Therapeutics
Performance |
| Timeline |
| Tastemaker Acquisition |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Lyra Therapeutics |
Tastemaker Acquisition and Lyra Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tastemaker Acquisition and Lyra Therapeutics
The main advantage of trading using opposite Tastemaker Acquisition and Lyra Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tastemaker Acquisition position performs unexpectedly, Lyra Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyra Therapeutics will offset losses from the drop in Lyra Therapeutics' long position.The idea behind Tastemaker Acquisition Corp and Lyra Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Lyra Therapeutics vs. CytomX Therapeutics | Lyra Therapeutics vs. Assembly Biosciences | Lyra Therapeutics vs. Achilles Therapeutics PLC | Lyra Therapeutics vs. Instil Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |